MTFB Motif Bio plc

7.18
+0  (0%)
Previous Close 7.15
Open 7.15
Price To book 2.57
Market Cap 38.99M
Shares 5,430,000
Volume 1,200
Short Ratio 2.72
Av. Daily Volume 4,115

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due 2H 2017.
Iclaprim - REVIVE-2
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 data released April 18, 2017 - primary endpoint of non-inferiority met.
Iclaprim -REVIVE-1
Acute bacterial skin and skin structure infections (ABSSSI)